Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
CNS
Study Phase
Study Completion Date
N/A
NCT02360215Uploaded 05-12-2021
Access via NCI by Request
PDS UID: nci-data-468
N/A
Provider Information
Provider Data DescriptionThis dataset contains baseline, treatment, efficacy, and health-related quality of life data from trial NCT02360215 to reproduce the results in the primary publication (PubMed ID 32058845). Dataset NCT02360215-D2 contains toxicity data for this publication.
SponsorNRG Oncology
Data ProviderNational Cancer Institute
Clinical Trials.gov Information
Brief SummaryN/A
ConditionsN/A
Intervention TypeN/A
Drug(s)N/A
Total EnrolledN/A
RandomizationN/A
Blinding MethodN/A
Arms InterventionN/A
Secondary IDN/A
PubMed (PMID)N/A
Collaborator(s)N/A
Region(s)N/A
Age RangeN/A
Files: NCT02360215-D1
Data DictionaryNCT02360215-D1-Data-Dictionary_1.pdf
DATANCT02360215-D1-Dataset_1.csv
OTHERREADME.pdf
Files: NCT02360215-D2
Data DictionaryNCT02360215-D2-Data-Dictionary_1.pdf
DATANCT02360215-D2-Dataset_1.csv
OTHERREADME.pdf
© 2023 Project Data Sphere
All rights reserved
Privacy PolicyTerms of Use